PRIMARY STUDY
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Key Findings: The currently available preclinical and clinical evidence points to CBD as a promising treatment strategy for these patient populations.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): Brazil
Year of Pub: 2019
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
